Slope
Ben Carmel has extensive work experience in the life sciences industry. Ben is currently serving as the Chief Revenue Officer (CRO) at Slope, where they are responsible for driving operational excellence for clinical trials. Previously, they worked as the Vice President of Global Sales at H1, where they played a crucial role in democratizing access to healthcare professional knowledge and insights. Before that, they held various roles at IQVIA, including Customer Strategy & Engagement Lead and Global Head of Business Development in the Commercial Compliance division. Ben also had a successful tenure at Polaris, a technology and consulting firm specializing in compliance solutions, where they started in consulting and eventually transitioned into sales leadership. Ben began their career as a Consultant at Accenture, leading projects for global pharmaceutical companies. Prior to that, they gained experience as a Business Development Intern at Azure Solutions and as a Finance & Marketing Intern at FlagHouse.
Ben Carmel attended the University of Colorado Boulder - Leeds School of Business from 2001 to 2005. During this time, they pursued a Bachelor of Science degree in Business with a focus on Finance and Marketing. Ben Carmel also holds a certification in Project Management Professional (PMP) from PMI, although the specific month and year of obtaining the certification are not mentioned.
This person is not in any offices
Slope
Slope provides a clinical trial execution platform for sponsors and research sites collaborating on complex, sample-intensive clinical trials. The platform reduces operational chaos for sponsors, CROs, research sites, and labs by providing data-driven oversight into clinical trial activities. Through Slope’s clinical inventory, sample management, and data-driven resupply solutions, the platform enables stakeholder collaboration, real-time visibility, traceable chain of custody, and risk mitigation. This results in improved trial outcomes — including boosting patient enrollment and retention — reduction of supply waste, and adherence to study protocols, timelines, and budgets.